Polaris Group (TPE:6550) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


TPE:6550 Polaris Group TPE:6550
59 GF Score
Price NT$13.05
GF Value NT$55.10
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Polaris Group Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Polaris Group's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

TPE:6550 vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Polaris Group's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polaris Group Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polaris Group's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Polaris Group's Margin of Safety % (DCF FCF Based) falls into.


TPE:6550
59GF Score
Polaris Group TPE:6550
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Polaris Group (TPE:6550) Overvalued in 2026?

Based on GuruFocus' analysis, Polaris Group stock appears to be undervalued. The current stock price of NT$13.05 is trading 76.3% below its estimated GF Value™ of NT$55.10. GuruFocus considers Polaris Group to be Possible Value Trap.

Key valuation signals for TPE:6550:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: NT$55.10 vs. price of NT$13.05 (76.3% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the TPE:6550 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Polaris Group Business Description

Address Ugland House, PO Box 309, Grand Cayman, CYM, KY1-1104
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.
59GF Score

Get the complete analysis for TPE:6550

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.05
Price
NT$55.10
GF Value